Clinical Trial Update: Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA) [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating allogenic stem cells derived from lipoaspirates for treating rectovaginal fistulas in Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Rectovaginal Fistula

Drugs mentioned

• Allogenic stem cells derived from lipoaspirates

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | Conditions: Rectovaginal Fistula, Crohn Disease | Phase 1, Phase 2 | Status: COMPLETED